ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"
NCT00051285 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1800
Last updated 2014-01-10
Summary
To determine if low-dose enoximone therapy is an effective treatment for advanced chronic heart failure.
Conditions
- Heart Failure, Congestive
Interventions
- DRUG
-
Enoximone
Participants receive oral enoximone
- DRUG
-
Enoximone placebo
Participants receive placebo to match enoximone
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-02-28
- Primary Completion
- 2005-06-30
- Completion
- 2005-06-30
More Related Trials
-
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
NCT01055912 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
NCT05659264 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
NCT01115855 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
NCT01971593 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
NCT03016325 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes
NCT01586442 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure
NCT04157751 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
NCT05636176 ·Status: RECRUITING ·Phase: PHASE3
-
Cardiovascular Genistein Therapy for Heart Failure Inflammation
NCT06501768 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Peroral Levosimendan in Chronic Heart Failure
NCT00130884 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
NCT01542502 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure
NCT01411735 ·Status: COMPLETED ·Phase: PHASE3
-
Study of JK07 in Patients With Chronic Heart Failure
NCT06369298 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction
NCT05672134 ·Status: COMPLETED ·Phase: PHASE2
-
ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy
NCT06580717 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
NCT02678312 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
NCT02842242 ·Status: COMPLETED ·Phase: PHASE2
-
v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
NCT03447990 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction
NCT05139615 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
NCT00454818 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT06122779 ·Status: RECRUITING ·Phase: PHASE2
-
Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product
NCT02804035 ·Status: COMPLETED ·Phase: PHASE2
-
TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.
NCT06117722 ·Status: RECRUITING
-
A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function
NCT03332186 ·Status: COMPLETED ·Phase: PHASE1